Hypoglycaemic and insulinotropic effects of a novel oral antidiabetic agent, (-)-N-(trans-4-isopropylcyclohexanecarbonyl)-D-phenylalanine (A-4166)
新型口服抗糖尿病药物(-)-N-(反式-4-异丙基环己烷羰基)-D-苯丙氨酸(A-4166)的降血糖和促胰岛素分泌作用
期刊:British Journal of Pharmacology
影响因子:7.7
doi:10.1038/sj.bjp.0700875
Ikenoue, T; Akiyoshi, M; Fujitani, S; Okazaki, K; Kondo, N; Maki, T